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Sugar-sweetened beverage (SSB) consumption is associated with obesity, diabetes, and
hypertension. Argentina is one of the major consumers of SSBs per capita worldwide. Deter-
mining the impact of SSB reduction on health will inform policy debates.
Methods and findings
We used the Cardiovascular Disease Policy Model-Argentina (CVD Policy Model-Argen-
tina), a local adaptation of a well-established computer simulation model that projects car-
diovascular and mortality events for the population 35–94 years old, to estimate the impact
of reducing SSB consumption on diabetes incidence, cardiovascular events, and mortality
in Argentina during the period 2015–2024, using local demographic and consumption data.
Given uncertainty regarding the exact amount of SSBs consumed by different age groups,
we modeled 2 estimates of baseline consumption (low and high) under 2 different scenarios:
a 10% and a 20% decrease in SSB consumption. We also included a range of caloric com-
pensation in the model (0%, 39%, and 100%). We used Monte Carlo simulations to generate
95% uncertainty intervals (UIs) around our primary outcome measures for each intervention
scenario. Over the 2015–2024 period, a 10% reduction in SSBs with a caloric compensation
of 39% is projected to reduce incident diabetes cases by 13,300 (95% UI 10,800–15,600
[low SSB consumption estimate]) to 27,700 cases (95% UI 22,400–32,400 [high SSB con-
sumption estimate]), i.e., 1.7% and 3.6% fewer cases, respectively, compared to a scenario
of no change in SSB consumption. It would also reduce myocardial infarctions by 2,500
(95% UI 2,200–2,800) to 5,100 (95% UI 4,500–5,700) events and all-cause deaths by 2,700
(95% UI 2,200–3,200) to 5,600 (95% UI 4,600–6,600) for “low” and “high” estimates of SSB
intake, respectively. A 20% reduction in SSB consumption with 39% caloric compensation is
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projected to result in 26,200 (95% UI 21,200–30,600) to 53,800 (95% UI 43,900–62,700)
fewer cases of diabetes, 4,800 (95% UI 4,200–5,300) to 10,000 (95% UI 8,800–11,200)
fewer myocardial infarctions, and 5,200 (95% UI 4,300–6,200) to 11,000 (95% UI 9,100–
13,100) fewer deaths. The largest reductions in diabetes and cardiovascular events were
observed in the youngest age group modeled (35–44 years) for both men and women; addi-
tionally, more events could be avoided in men compared to women in all age groups. The
main limitations of our study are the limited availability of SSB consumption data in Argen-
tina and the fact that we were only able to model the possible benefits of the interventions
for the population older than 34 years.
Conclusions
Our study finds that, even under conservative assumptions, a relatively small reduction in
SSB consumption could lead to a substantial decrease in diabetes incidence, cardiovascu-
lar events, and mortality in Argentina.
Author summary
Why was this study done?
• Sugar-sweetened beverages (SSBs) are associated with obesity, hypertension, and
diabetes.
• Argentina is one of the largest consumers of SSBs, particularly sodas, in the world.
• When considering measures aimed at reducing SSB consumption, such as a soda tax,
policy makers need evidence-based estimates of potential health benefits.
What did the researchers do and find?
• We first developed and updated an Argentinian version of the Cardiovascular Disease
Policy Model (CVD Policy Model), a well-established computer simulation model
already used in the United States and Mexico to estimate cardiovascular health
outcomes.
• We used the CVD Policy Model-Argentina to determine the potential impact of a
reduction in soda consumption on diabetes, cardiovascular diseases (CVDs), and mor-
tality among adults 35–94 years of age over a 10-year period (2015–2024).
• A 10% reduction in soda consumption is projected to avert between 13,300 to 27,700
diabetes cases, 2,500 to 5,100 myocardial infarctions, and 2,700 to 5,600 all-cause deaths
over a 10-year period.
• The largest reductions in diabetes and cardiovascular events were observed in the youn-
gest age group modeled (35–44 years) for both men and women; additionally, more
events could be avoided in men compared to women in all age groups.
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(https://estudiocescas.iecs.org.ar/), the 2013
National Risk Factor Survey (http://www.msal.gob.
ar/ent/index.php/vigilancia/publicaciones/
encuestas-poblacionales), and the PrEViSTA study
(https://www.ncbi.nlm.nih.gov/pubmed/
24024917). Framingham Heart Study data are
available following approval of research
applications submitted through the National Heart,
Lung, and Blood Institute’s Biologic Specimen and
Data Repository Information Coordinating Center
(available at http://biolincc.nhlbi.nih.gov/studies/
framcohort/?q=framingham for the Framingham
Cohort and http://biolincc.nhlbi.nih.gov/studies/
framoffspring/?q=framingham for the Offspring
study). Data on sugar sweetened beverage
consumption come from CESCAS I study (https://
estudiocescas.iecs.org.ar/), the 2005 National




argentina). Vital statistics and census data are
publicly available from government sources
described in the paper.
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What do these findings mean?
• A relatively small reduction in SSB consumption could lead to a substantial decrease in
diabetes incidence, cardiovascular events, and mortality in Argentina.
• These results support the implementation of policies to reduce SSB consumption, such
as a soda tax. Use of taxation as a health policy tool would have the additional advantage
of providing a new source of public funds to support healthy lifestyles.
Introduction
As one of the main sources of added sugar in Western diets, sugar-sweetened beverage (SSB)
consumption is suggestive of poor dietary quality [1] and is associated with obesity, type 2 dia-
betes mellitus (from now on, referred to only as “diabetes”), and hypertension [2–8]. While
sales of sweet soft drinks in North America leveled off after 2012, in Latin America they dou-
bled in the period 2000–2013 [9]. Increased SSB consumption during this time period was
strongly correlated with growing rates of overweight and obesity in the region [9].
Argentina is one of the world’s highest consumers of SSBs, with consumption estimates of
120 to 130 liters of SSB per capita per year [10,11]. Between 2005 and 2013, the combined over-
weight and obesity prevalence in Argentina rose from 49% to 58%; 21% of the population pre-
sented obesity in 2013 [12]. This increase in obesity has contributed to rising rates of diabetes
—diagnosed in 9.8% of Argentines in 2013 [12]—and to Argentina’s very high rates of cardio-
vascular disease (CVD) [9]. Given that relatively small increases in weight heighten the risk of
diabetes and CVD [13–16], SSBs may contribute to disease development even among individ-
uals without obesity.
Due to the increase in obesity prevalence and its related illnesses, reducing SSB consump-
tion—which in Argentina consists overwhelmingly of sugary sodas [10]—is a public health
priority. The World Health Organization has suggested SSB taxation as a fiscal policy interven-
tion for the prevention of noncommunicable diseases [17]. The success of Mexico’s SSB tax,
which led to an 11% price increase followed by a 7.3% reduction in SSB sales within the first 2
years, has placed SSB taxes on the menu of policy options for all Latin American countries
[18].
In order to provide local policy makers estimates of the projected impact of SSB taxation
on the health of the Argentine population, we used a well-established computer simulation
model, the Cardiovascular Disease Policy Model (CVD Policy Model), adapted for the Argen-
tine population, to simulate the impact of reduced SSB consumption on national diabetes
incidence, cardiovascular events, and mortality.
Methods
CVD Policy Model-Argentina
The CVD Policy Model is a computer simulation, state transition (Markov) model that esti-
mates the prevalence and incidence of CVD by using demographic, epidemiological, vital
statistic, and hospital data measured in the population 35 years old and older. The model sepa-
rates the population into those without and with CVD. Those without CVD are stratified into
cells defined by sex, age decile, and levels of the following cardiovascular risk factors: systolic
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blood pressure (SBP; <130; 130–139.9; �140 mmHg), low-density lipoprotein cholesterol
(<100; 100–129.9; �130 mg/dl), high-density lipoprotein cholesterol (<40; 40–59.9; �60 mg/
dl), smoking status (no exposure, second-hand smoke exposure, active smoking), type 2 diabe-
tes status (yes versus no), and body mass index (BMI) (<25; 25–29.9; �30 kg/m2). In annual
cycles, those without preexisting CVD have probabilities of experiencing incident coronary
heart disease (CHD), incident stroke, or death from non-cardiovascular causes, with transition
rates dependent on age, sex, and risk factor values. The population with prior CVD has annual
rates of recurrent cardiovascular events or death from cardiovascular or non-cardiovascular
causes, with transition rates dependent on age, sex, and prior CVD status. Each annual cycle,
new 35-year-olds enter the simulated population, measured from census projections [19,20],
and those who die or reach 95 years of age exit the simulated population.
The first version of the CVD Policy Model-Argentina was developed in 2009 [21]. Since
then, new sources of information have become available and have replaced original inputs,
including the 2010 National Census [22–24], the 2013 National Risk Factor Survey [12], the
Study for the Detection and Follow-up of Cardiovascular Disease Risk Factors in the Southern
Cone of Latin America (CESCAS I study) [25], and the Program for the Epidemiological Eval-
uation of Stroke in Tandil (PrEViSTA) [26]. The updated version of the model was calibrated
with an accuracy of 99.5% when comparing CVD events and deaths predicted by this model
and those observed in national data for 2010 [27]. A more detailed explanation of model devel-
opment and update can be found in the S1 Appendix, as well as in a previous publication [27].
The study’s prospective protocol can be found in the S1 Protocol. This study is reported as
per the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)
guideline (S1 STROBE Checklist).
Estimating daily SSB consumption in Argentina
To model the impact of a decrease in SSB consumption on cardiovascular health, we first esti-
mated per capita daily consumption of SSBs in Argentina by sex and age group. We focused
specifically on sugar-sweetened soda consumption (hereafter labeled “SSB”) and estimated
mean daily 12-ounce servings of these beverages. This serving size is equivalent to a can of
soda in Argentina. Due to a lack of a single source of nationally representative data on SSB
consumption for each age and sex stratum modeled, we generated 2 sets of estimates (a “low”
estimate and a “high” estimate) using the best available data and modeled both scenarios to
represent the range of likely SSB intake in the population.
We obtained our “low” estimates from the CESCAS I study, an ongoing observational pro-
spective cohort designed to study CVD prevalence and risk factors in Southern Latin America.
In 2010–2011, CESCAS I measured self-reported average daily SSB consumption among 3,300
adults aged 35 to 74 years old in 2 Argentinean cities (Bariloche and Marcos Paz) [25]. The
questionnaire was based on the Spanish version of the Dietary History Questionnaire I, a self-
administered food-frequency questionnaire developed for the Spanish-speaking population in
the US [28] and validated for use in Argentina [29]. We assumed that consumption among
people 75 years of age and older was equivalent to that reported by those 65 to 74 years old.
We derived a “high” estimate using the 2005 National Nutrition and Health Survey
(Encuesta Nacional de Nutrición y Salud [ENNyS]) in combination with sales report data
from Euromonitor measured in 2005 and 2015. The ENNyS, a survey conducted in 2005
among Argentine women 10 to 49 years old [30], reported mean daily soda consumption. We
applied that figure to women aged 35–44 years in the model. However, recognizing that daily
soda consumption includes both regular and diet soda, we estimated the consumption of regu-
lar soda by using the fraction of regular soda (87.1%) that makes up sales of total soda (regular
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and diet) in the 2005 Euromonitor sales data [10]. Finally, we compared Euromonitor overall
sales data in 2015 to 2005 and corrected for the difference in population size between those
years. By doing so, we derived a mean daily consumption of regular soda of 269.6 ml for
women 35–44 years old in 2015. We then generated estimates of SSB intake for each age/gen-
der group by scaling to the proportional intake observed for each group relative to 35- to
44-year-old women as measured in CESCAS I. A more detailed description of these calcula-
tions, as well as a comparison with CESCAS I reported consumption, can be seen in S1
Appendix.
SSB effect on CVD risk factors
SSB consumption has been shown to have a direct effect on SBP and diabetes, as well as indi-
rect effects on SBP and diabetes that are mediated through changes in BMI [2–4,8]. We mod-
eled both direct and indirect effects of reductions in SSB consumption using inputs shown in
Table 1. The model applies all changes in the first year of the simulation and then assumes that
they are held constant.
We assumed that decreasing intake of SSB by one 12-ounce serving per day is associated
with a reduction in SBP of 0.78 mmHg (95% CI 0.09–1.47) in men and 0.61 mmHg (95% CI
0.27–1.48) in women independent of SBP changes mediated through BMI [31]; similarly, BMI-
independent diabetes risk was assumed to decrease by a factor of 1.19 (95% CI 1.09–1.31) [32].
Weight and height information for the Argentina population was obtained from the 2013
National Risk Factor Survey [12], and changes in weight assumed for the interventions were
converted into changes in kilograms per square meter of BMI. Each unit kilogram-per-
square-meter decrease in BMI was assumed to result in a 1.43 mmHg and 1.24 mmHg
decrease in SBP in men and women, respectively [33]. The association between changes in
BMI and changes in diabetes incidence was estimated using Framingham Heart Study data
[34–38].
We assumed that changes in SSB consumption were associated with changes in weight
using the conversion 3,500 kcal = 1 pound; one serving of soda contains 150 calories [39].
Although imbalances between the intake and utilization rates of macronutrients will result in
changes in body weight, the relationship between caloric consumption and weight loss/gain, as
well as caloric compensation when reducing one source of calories, are not fully understood.
Table 1. Effect of 12-ounce serving size of SSB on diabetes incidence, BMI, and SBP.
Variable SSB consumption effect
SBP; SSB consumption independent effect Men: 0.78 mmHg (0.09–1.47)
Women: 0.61 mmHg (0.27–1.48) [31]
Independent effect of 1 additional serving of SSB on risk of diabetes, RR
(95% CI)
1.19 (1.09–1.31) [32]
SBP; SBP change per 1-unit increase in BMIa Men: 1.43 mmHg (1.23–1.64)
Women: 1.24 mmHg (1.09–1.39) [33]
Association between a 1-unit increase in BMI and incident diabetes, RR
(95% CI)a
Decreases over age;
1.17 (0.97–1.43) for 55–64 years old
[34–38]
BMI Calories from SSB translated to weight;
3,500 calories = 1 pound [39]
aBMI-mediated changes in diabetes and SBP are expressed for each unit kg/m2 change in BMI.
Abbreviations: BMI, body mass index; RR, relative risk; SBP, systolic blood pressure; SSB, sugar-sweetened soda
https://doi.org/10.1371/journal.pmed.1003224.t001
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Consequently, we decided to include 3 scenarios with different degrees of caloric compensa-
tion (and therefore different changes in BMI) after a decrease in SSB consumption: 100%, 39%
(a reported average compensation rate), and 0% caloric compensation scenarios [40,41].
Under assumptions of 100% calorie compensation (i.e., no change in BMI), the independent
effect of SSB consumption on SBP and diabetes drives changes in CVD outcomes.
A more detailed description of our approach to modeling the relationship between changes
in SSB consumption and CVD risk factors and outcomes was published in our previous work
on SSB in the US and Mexico [42,43].
Model simulations
We modeled the impact of a reduction in SSB consumption on diabetes incidence, myocardial
infarctions, strokes, CVD mortality, and all-cause mortality using the CVD Policy Model-
Argentina over a 10-year period from 2015 to 2024.
A recent analysis estimated that the price elasticity of soda consumption in Argentina is
very close to 1 (−1.12) [44]. Therefore, we assumed that a 10% or 20% tax could translate into
a 10% or 20% decrease in soda consumption (assuming that all, or nearly all, of the cost from
the tax is passed on to the consumer) and compared the health impacts of each taxation sce-
nario to the base case of no change in consumption. We also modeled a 40% reduction in SSBs
which, though difficult to achieve at a population level, highlights the potential benefits of very
high reduction in soda consumption. We applied each taxation scenario to both our “low” and
“high” estimates of current SSB consumption in Argentina, and our main analyses assumed
39% calorie compensation [41].
Probabilistic sensitivity analyses
We used Monte Carlo simulations to generate 95% uncertainty intervals (UIs) around our pri-
mary outcome measures for each intervention scenario. The 95% confidence intervals for esti-
mates of the effect of changes in SSB consumption on SBP and on diabetes risk as well as the
beta inputs for model risk functions defining the relationship between risk factors and incident
diabetes, incident CHD, incident stroke, and non-CVD death are included in Table C of S1
Appendix. There were 1,000 random draws from a standard normal distribution, scaled to the
mean and confidence interval, for each varied parameter. The Monte Carlo program, written
in Python, generated a new set of input parameters drawn from the distributions for each iter-
ation, ran the given iteration base case and reduced SSB consumption simulations with the
new parameters, and stored the outcomes for each iteration. The 95% UIs for each outcome
were then calculated using Microsoft Excel 2016.
Results
Over the 2015–2024 period, a 10% reduction in SSB consumption with a caloric compensation
of 39% is projected to reduce diabetes cases by between 13,300 (95% UI 10,800–15,600 [low
SSB consumption estimate]) and 27,700 cases (95% UI 22,400–32,400 [high SSB consumption
estimate]), i.e., 1.7% and 3.6% fewer cases, respectively, compared to a scenario of no change
in SSB consumption. This same scenario leads to an estimated 2,500 (95% UI 2,200–2,800) to
5,100 (95% UI 4,500–5,700) fewer myocardial infarctions, 1,900 (95% UI 1,600–2,200) to 3,900
(95% UI 3,400–4,400) fewer CVD deaths, and 2,700 (95% UI 2,200–3,200) to 5,600 (95% UI
4,600–6,600) fewer deaths from any cause for “low” and “high” estimates of baseline SSB
intake, respectively. A 20% reduction in SSB consumption with 39% caloric compensation is
projected to result in 26,200 (95% UI 21,200–30,600) to 53,800 (95% UI 43,900–62,700) fewer
cases of diabetes, 4,800 (95% UI 4,200–5,300) to 10,000 (95% UI 8,800–11,200) fewer
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myocardial infarctions, and 5,200 (95% UI 4,300–6,200) to 11,000 (95% UI 9,100–13,100)
fewer deaths (Table 2).
Fig 1 shows the prevented cases of myocardial infarction, stroke, and deaths by gender and
age group for the 10% consumption reduction scenario in the 10-year period. The magnitude
of prevented cases was highest among men and in the youngest ages modeled, and lowest in
the highest ages modeled.
Table 3 presents results from 0% and 100% caloric compensation scenarios, assuming a
10% reduction in SSB consumption. When varying the degree of caloric compensation, even
under the most conservative assumption of base SSB consumption (low estimate), the reduc-
tion in diabetes ranges from 5,100 (95% UI 3,000–7,100) fewer cases assuming 100% caloric
compensation (0.7% relative reduction) to 18,300 (95% UI 15,000–21,200) fewer cases (2.3%
relative reduction) if we assume 0% caloric compensation.
The decreased rate of incident diabetes cases under the 6 scenarios of taxation and caloric
compensation (10% and 20% consumption reduction, 0%, 39%, and 100% caloric compensa-
tion), for low and high estimates of current SSB consumption, can be seen in Fig 2. In each sce-
nario, most of the prevented cases occur in the youngest age groups for both women and men.
In an extreme scenario of achieving a 40% reduction of SSB consumption along with 39%
caloric compensation, we estimate 49,800 (95% UI 40,400–58,200) to 101,100 (95% UI 74,200–
117,300) fewer cases of diabetes, 9,500 (95% UI 8,400–10,600) to 19,700 (95% UI 16,900–
22,000) fewer myocardial infarctions, and from 10,400 (95% UI 8,500–12,300) to 21,600 (95%
UI 16,800–25,700) fewer deaths, respectively, for low and high estimates of baseline SSB
consumption.
Discussion
The need to reduce SSB consumption in Argentina is increasingly a matter of policy discus-
sions in response to growing levels of obesity amidst very high levels of SSB consumption.
Table 2. Projected cumulative cases of diabetes, CVD events, and deaths prevented for the period 2015–2024, assuming 39% caloric compensation, under two sce-
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CVD deaths: deaths due to CHD + stroke.
Abbreviations: CHD, coronary heart disease; CVD, cardiovascular disease; SSB, sugar-sweetened beverage or soda; UI, uncertainty interval
https://doi.org/10.1371/journal.pmed.1003224.t002
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L o c al e vi d e n c e  w o ul d b est i nf or m t h at d e b at e.  Usi n g a v ali d at e d c o m p ut er si m ul ati o n  m o d el
p o p ul at e d  wit h  Ar g e nti n e d at a,  w e f o u n d t h at a 1 0 % r e d u cti o n i n S S B c o ns u m pti o n a m o n g
t h os e a g e d 3 5 y e ars a n d ol d er c o ul d r e d u c e di a b et es b y a  m a g nit u d e of 5, 1 0 0 c as es (i n a n
e xtr e m el y c o ns er v ati v e s c e n ari o) t o 3 8, 2 0 0 c as es o v er 1 0 y e ars,  wit h a  m ost li k el y i m p a ct b ei n g
b et w e e n 1 3, 3 0 0 t o 2 7, 7 0 0 c as es a v ert e d.  T h es e l ast fi g ur es  w o ul d b e e q ui v al e nt t o 1 t o 2 c as es of
di a b et es a v oi d e d f or e v er y 1, 4 0 0 p e o pl e o v er 3 4 y e ars of a g e.  C ar di o v as c ul ar e v e nts a n d  m ort al-
it y c o ul d als o b e si g nifi c a ntl y r e d u c e d.
It is  w ort h u n d ers c ori n g t h at, si n c e t h e a v er a g e d ail y c o ns u m pti o n of s o d as is gr e at er
a m o n g y o u n g p e o pl e,  m ost pr e v e nt e d c as es of di a b et es o c c ur i n t his p o p ul ati o n.  T h e tr u e
h e alt h b e n efits of S S B t a x ati o n c o ul d b e hi g h er t h a n t h os e  w e pr es e nt h er e, as a 1 0- y e ar esti-
m at e of a v oi d e d c as es of  C V D a n d d e at h is a r el ati v el y s h ort ti m e p eri o d i n  w hi c h t o p er c ei v e
cli ni c al i m p a ct a m o n g y o u n g a n d  mi d dl e- a g e d a d ults.
A pr e vi o us a n al ysis c o n d u ct e d i n  M e xi c o usi n g t h e  C V D P oli c y  M o d el- M e xi c o f o u n d t h at
a 1 0 % d e cr e as e i n c o ns u m pti o n, ass u mi n g 3 9 % c al ori c c o m p e ns ati o n, c o ul d pr e v e nt al m ost
1 9 0, 0 0 0 di a b et es c as es o v er a 1 0- y e ar p eri o d,  m a n y  m or e t h a n t h e 1 3, 3 0 0 t o 2 7, 7 0 0 c as es r es ulti n g
Fi g 1.  P r oj e ct e d p r e v e nt e d c as es as p e r c e nt of  MI, st r o k es,  C V D d e at hs, a n d o v e r all d e at hs b y a g e g r o u p a n d g e n d e r, 2 0 1 5 – 2 0 2 4, ass u mi n g 1 0 %
r e d u cti o n i n S S B c o ns u m pti o n, u n d e r t w o s c e n a ri os of b as eli n e S S B c o ns u m pti o n. C V D, c ar di o v as c ul ar dis e as e;  MI,  m y o c ar di al i nf ar cti o n; S S B,
s u g ar-s w e et e n e d s o d a.
htt p s:// d oi. or g/ 1 0. 1 3 7 1/j o ur n al. p m e d. 1 0 0 3 2 2 4. g 0 0 1
P L O S M E DI CI N E S u g ar- s w e et e n e d b e v er a g e c o n s u m pti o n r e d u cti o n a n d c ar di o v a s c ul ar di s e a s e i n  Ar g e nti n a
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p o p ul ati o n ( al m ost 3 ti m es l ar g er t h a n  Ar g e nti n a’s) [ 4 5 ,4 6 ], a hi g h er a v er a g e d ail y S S B c o ns u m p-
ti o n i n t h e  M e xi c o a n al ysis (t h at a d diti o n all y i n cl u d e d all s u g ar y dri n ks), a n d a c urr e nt hi g h er
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after year 2 indicate that taxed beverages per capita sales were reduced by 7.3%, while per capita
sales of plain water increased 5.2% [18]. Mexico’s experience informs what Argentina could fore-
see as expected benefits of a tax policy aimed at reducing SSB consumption.
Our study limitations are mainly related to the limited availability of SSB consumption data
in Argentina. We have undertaken several strategies to obtain valid estimates given these limi-
tations, and we present a range of assumptions. The SSB daily serving size as reported by the
CESCAS I study (which provides our “low” intake estimate) is likely to be underestimating
total consumption. This would bias our results toward a more conservative estimate of health
benefits. We have also modeled the health benefits of a consumption reduction using an alter-
native, less conservative, estimate of current SSB intake in the population. Additionally, our
main scenario assumes a 39% caloric compensation; this estimate comes from US data [41]
and may be higher or lower in Argentina or could vary in a systematic way over time. Also,
the effect size and all model parameters are held constant, varying only by age as the popula-
tion ages, which is both a strength and a limitation of modeling. To account for these possibili-
ties, we have also modeled the 2 extremes cases of 0% and 100% caloric compensation. Finally,
we were only able to model the possible benefits for the population older than 34 years—the
age range analyzed by the CVD Policy Model—and for a 10-year period. As most sodas are
consumed by younger people, the health benefits of consumption reduction could be higher
among younger generations over time.
Despite uncertainty about the distribution of SSB consumption among Argentina’s popula-
tion, the government will need to make public health policy decisions about whether and how
to limit SSB consumption. Our study finds that, even under conservative assumptions, a rela-
tively small reduction in SSB consumption could lead to a significant decrease in diabetes inci-
dence, CVD events, and mortality. These results support policies to increase the price of these
products using taxation as a potential tool to reduce SSB consumption, which would have the
additional advantage of providing a new source of public funds to support healthy lifestyles.
Argentina has previously used computer simulation research results to foster national pol-
icy development. For example, other modeling studies on tobacco control [47] and salt con-
sumption [48] (using the CVD Policy Model-Argentina) highlighted the impact of potential
policies that were subsequently implemented. The results of this study should contribute to
the development and implementation of evidence-based policies aimed at decreasing SSB
consumption in Argentina.
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